Jaw-in-a-day (JIAD) for malignant indications: A systematic review
JIAD for HNC patients can have high success in majority of select patients/defects. Although early osseointegration rates were high, oncologic patients receiving adjuvant radiation may remain at elevated risk for ORN-associated prosthesis failure. As such, the risks and benefits of JIAD should be carefully reviewed with the patient, and cancer staging should also be considered.
Authors
- Rashi Ramchandani (ORCID: https://orcid.org/0000-0002-6144-6423)
- P Dutta
- Noémie Villemure‐Poliquin (ORCID: https://orcid.org/0000-0003-0428-6141)
- Danny Enepekides (ORCID: https://orcid.org/0000-0001-8932-7314)
- J Davies
- Leba M. Sarkis (ORCID: https://orcid.org/0000-0003-3791-4925)
- Antoine Eskander (ORCID: https://orcid.org/0000-0003-4326-1393)
- Justine Philteos (ORCID: https://orcid.org/0000-0002-3526-1345)
- Nick Blanas (ORCID: https://orcid.org/0000-0001-7324-5437)
- Kevin Higgins (ORCID: https://orcid.org/0000-0001-5760-1390)
- Karl Cuddy
- Eszter Somogyi‐Ganss (ORCID: https://orcid.org/0000-0002-4272-6155)
- Jessica Trac
- Robert Calvisi
Institutions
- The University of Sydney (AU)
- St. Michael's Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- University of Ottawa (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Toronto Rehabilitation Institute (CA)
- Toronto East General Hospital (CA)
- Sinai Health System (CA)
Publication Details
- Journal
- Oral Oncology
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1016/j.oraloncology.2025.107823
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05